Phocas Financial Corp’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.81M Sell
292,510
-15,636
-5% -$178K 0.53% 79
2026
Q1
$3.5M Sell
308,146
-298,127
-49% -$3.23M 0.55% 76
2025
Q4
$7.78M Sell
606,273
-1,551
-0.3% -$19.1K 1.01% 32
2025
Q3
$6.79M Buy
607,824
+269,416
+80% +$2.6M 0.88% 48
2025
Q2
$3.36M Buy
338,408
+50
+0% +$489 0.48% 82
2025
Q1
$3.18M Buy
+338,358
New +$3.56M 0.49% 88

Other funds holding ANGO

Phocas Financial Corp's ANGO Position: Q2 2026 in Review

Phocas Financial Corp reduced its AngioDynamics (ANGO) stake by 5.1% in Q2 2026, selling an estimated $178K and leaving 292,510 shares worth $3.81M. The position accounts for 0.53% of the portfolio, ranked #79.

Phocas Financial Corp first reported a position in ANGO in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.78M in Q4 2025. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Phocas Financial Corp held 292,510 shares of AngioDynamics worth $3.81M as of Q2 2026.
  • Phocas Financial Corp sold 15,636 AngioDynamics shares in Q2 2026, an estimated $178K.
  • AngioDynamics made up 0.53% of Phocas Financial Corp's portfolio in Q2 2026, its #79 holding.
  • Phocas Financial Corp first reported a position in AngioDynamics in Q1 2025 and has held it in 6 quarters since.
  • Phocas Financial Corp's AngioDynamics position peaked at $7.78M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Phocas Financial Corp's 13F filing for Q2 2026, filed 31 Jul 2026.